Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 1
1952 2
1953 1
1954 1
1956 2
1958 1
1974 2
1975 1
1979 2
1980 6
1981 7
1982 1
1983 1
1985 1
1986 1
1987 2
1988 5
1989 3
1990 8
1991 5
1992 12
1993 9
1994 11
1995 16
1996 13
1997 9
1998 19
1999 22
2000 15
2001 35
2002 20
2003 23
2004 17
2005 23
2006 24
2007 30
2008 38
2009 30
2010 49
2011 59
2012 40
2013 60
2014 59
2015 52
2016 58
2017 46
2018 46
2019 47
2020 66
2021 66
2022 64
2023 66
2024 67
2025 42

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,188 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
Motzer RJ, Tannir NM, McDermott DF, Arén Frontera O, Melichar B, Choueiri TK, Plimack ER, Barthélémy P, Porta C, George S, Powles T, Donskov F, Neiman V, Kollmannsberger CK, Salman P, Gurney H, Hawkins R, Ravaud A, Grimm MO, Bracarda S, Barrios CH, Tomita Y, Castellano D, Rini BI, Chen AC, Mekan S, McHenry MB, Wind-Rotolo M, Doan J, Sharma P, Hammers HJ, Escudier B; CheckMate 214 Investigators. Motzer RJ, et al. Among authors: grimm mo. N Engl J Med. 2018 Apr 5;378(14):1277-1290. doi: 10.1056/NEJMoa1712126. Epub 2018 Mar 21. N Engl J Med. 2018. PMID: 29562145 Free PMC article. Clinical Trial.
[Immunotherapy].
Grimm MO, Loidl W. Grimm MO, et al. Urologe A. 2018 Nov;57(11):1299-1300. doi: 10.1007/s00120-018-0796-y. Urologe A. 2018. PMID: 30406452 German. No abstract available.
In Reply.
Bolenz C, Schröppel B, Eisenhardt A, Schmitz-Dräger BJ, Grimm MO. Bolenz C, et al. Among authors: grimm mo. Dtsch Arztebl Int. 2019 Mar 8;116(11):192-193. doi: 10.3238/arztebl.2019.0192b. Dtsch Arztebl Int. 2019. PMID: 31014454 Free PMC article. No abstract available.
Phase-III-Studie beim lokalen oder lokal fortgeschrittenen Prostatakarzinom: Randomisierte, doppelblinde, Placebo-kontrollierte Phase 3 Studie zu Apalutamide in Patienten mit lokalem Hoch-Risiko-Prostatakarzinom oder lokal fortgeschrittenem Prostatakarzinom, die eine primäre Radiotherapie erhalten (ATLAS) – Studie AP 90/15 der AUO.
Rexer H, Graefen M Prof Dr, Grimm MO Prof Dr. Rexer H, et al. Among authors: grimm mo prof dr. Aktuelle Urol. 2017 Dec;48(6):520-521. doi: 10.1055/s-0043-119917. Epub 2017 Dec 7. Aktuelle Urol. 2017. PMID: 29216658 Clinical Trial. German. No abstract available.
BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis.
Schmitt A, Grimm M, Kreienkamp N, Junge H, Labisch J, Schuhknecht L, Schönfeld C, Görsch E, Tibello A, Menck K, Bleckmann A, Lengerke C, Rosenbauer F, Grau M, Zampieri M, Schulze-Osthoff K, Klener P, Dolnikova A, Lenz G, Hailfinger S. Schmitt A, et al. Among authors: grimm m. Blood. 2023 Sep 28;142(13):1143-1155. doi: 10.1182/blood.2022019274. Blood. 2023. PMID: 37294920 Free article.
[Travel medicine].
Schubert S, Grimm M. Schubert S, et al. Among authors: grimm m. Internist (Berl). 2009 Jul;50(7):841-51. doi: 10.1007/s00108-009-2433-8. Internist (Berl). 2009. PMID: 19484193 Review. German.
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial.
Motzer RJ, Bex A, Russo P, Tomita Y, Cutuli HJ, Rojas C, Gross-Goupil M, Schinzari G, Melichar B, Barthélémy P, Ruiz Garcia A, Sosman J, Grimm MO, Goh JC, Suarez C, Kollmannsberger CK, Nair SG, Shuch BM, Huang J, Simsek B, Spiridigliozzi J, Lee CW, van Kooten Losio M, Grünwald V. Motzer RJ, et al. Among authors: grimm mo. J Clin Oncol. 2025 Jan 10;43(2):189-200. doi: 10.1200/JCO.24.00773. Epub 2024 Sep 20. J Clin Oncol. 2025. PMID: 39303200 Free PMC article. Clinical Trial.
Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial.
Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, Grimm MO, Bedke J, Barthélémy P, Castellano D, Mellado B, Ivanyi P, Rottey S, Flörcken A, Suarez C, Maroto P, Grünwald V, Oosting SF, Kopecky J, Zschäbitz S, Boegemann M, Buchler T, Niegisch G, Goebell PJ, Waddell T, Joly F, Priou F, Retz M, Siemer S, Zimmermann U, Deckbar D, Burkholder I, Hartmann A, Haanen JB; Interdisciplinary Renal Cell Carcinoma Working Group of the DKG (IAGN). Bergmann L, et al. Among authors: grimm mo. Ann Oncol. 2025 Jul;36(7):796-806. doi: 10.1016/j.annonc.2025.03.016. Epub 2025 Apr 1. Ann Oncol. 2025. PMID: 40180121 Free article. Clinical Trial.
1,188 results